Laboratory Analyzer segment has the Largest Share of Product Type in the Europe Hemostasis Analyzers Market during 2020–2028 

According to a new market research study on “Europe Hemostasis Analyzers Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Test, End User and Country” is expected to reach US$ 1,970.20 million by 2028 from US$ 1,057.50 million in 2021. The market is estimated to grow at a CAGR of 9.3% from 2021 to 2028. The report provides trends prevailing in the Europe hemostasis analyzers market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to rising number of cardiovascular diseases and rise in the geriatric population are the key factors driving the market growth. However, the market is expected to experience slow growth during the forecast period owing to high cost of fully automated hemostasis analyzer.

After Asia, the European region is highly affected by the outbreak of the COVID-19 pandemic. Countries like Italy, Spain, the UK, Germany, France, and other European counties such as Russia, Switzerland are highly affected. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most affected European countries, and the number of deaths is also high. According to the International Health Regulation, the current coronavirus (COVID-19) outbreak has been declared by WHO as a Public Health Emergency of International Concern. The blood clots associated with the COVID19 infection and the specific vaccines are among the critical concern. However, the incidence of blood clotting due to the COVID19 vaccine is rare, and the region's regulatory agencies in the region have confirmed it is closely monitored. Therefore, it is expected that the growth of the market is likely to be slower in the following few years.

The market for Europe Hemostasis Analyzers Market is segmented into the product type, test, end user and country. Based on product type, the Europe Hemostasis Analyzers Market is segmented into laboratory analyzer, and point-of-care testing systems, whereas laboratory analyzer sub segmented   into automated systems, semi-automated systems, and manual systems. In 2021, the laboratory analyzer segment accounted for the largest market share. The growth of these segments is attributed to an increase in the prevalence of chronic illnesses like blood disorders and cardiovascular diseases, development of point of care (POC) coagulation testing, and the surge in laboratory automation is likely to create opportunity in the forecast year. However the point-of-care testing systems segment is estimated to register the highest CAGR during the forecast period.

Siemens Healthineers AG, Abbott, Sysmex Corporation, Nihon Kohden Corporation, THERMO FISHER SCIENTIFIC INC., HOFFMANN-LA ROCHE LTD., Instrumentation Laboratory Company. Among the leading companies in the Europe hemostasis analyzers market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

The market for Europe hemostasis analyzers market is segmented into product type, test, and end user. Based on product type, the Europe hemostasis analyzers market is segmented into laboratory analyzer [automated systems, semi-automated systems, and manual systems], and point-of-care testing systems. Based on test, the Europe hemostasis analyzers market is segmented into activated partial thromboplastin time, d-dimer test, fibrinogen test, prothrombin time (PT) test, and others. Based on end user, the Europe hemostasis analyzers market is segmented into hospitals/ clinics, independent diagnostic laboratories, home care setting, and others. By Geographically, Europe hemostasis analyzers market is segmented into (UK, Germany, France, Italy, Spain and Rest of Europe).

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com